Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Study ITI-007-035 is a Phase 1b, multicenter, open-label study to evaluate the safety, tolerability, and PK of lumateperone for pediatric patients with Autism Spectrum Disorder.
Epistemonikos ID: 7e0c735d902a2e55acfdae1e7cfa6c039736f3f0
First added on: Sep 01, 2024